Back to User profile » Dr Fangfang Lai

Papers published by Dr Fangfang Lai:

Original Research

CAT3, a prodrug of 13a(S)-3-hydroxyl-6,7-dimethoxyphenanthro[9,10-b]-indolizidine, circumvents temozolomide-resistant glioblastoma via the Hedgehog signaling pathway, independently of O6-methylguanine DNA methyltransferase expression

Ji M, Wang L, Chen J, Xue N, Wang C, Lai F, Wang R, Yu SS, Jin J, Chen X

OncoTargets and Therapy 2018, 11:3671-3684

Published Date: 25 June 2018

Original Research

LXY6090 – a novel manassantin A derivative – limits breast cancer growth through hypoxia-inducible factor-1 inhibition

Lai F, Liu Q, Liu X, Ji M, Xie P, Chen X

OncoTargets and Therapy 2016, 9:3829-3840

Published Date: 24 June 2016